Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

77.66 USD UNCHANGED
Streaming Delayed Price Updated: 7:59 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 77.66
Bid (Size) 77.67 (1)
Ask (Size) 77.76 (1)
Prev. Close 77.66
Today's Range 77.66 - 77.66
52wk Range 71.71 - 87.80
Shares Outstanding 2,530,315,668
Dividend Yield 3.35%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Hot Biotech Penny Stocks To Watch In April 2021
April 15, 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
3 Penny Stocks To Watch As Biotech Jumps In April 2021
April 15, 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed

Performance

YTD
-4.08%
-4.08%
1 Month
+0.19%
+0.19%
3 Month
-6.65%
-6.65%
6 Month
-1.28%
-1.28%
1 Year
-6.55%
-6.55%

More News

Read More
Merck Expands Safer Childbirth Cities Initiative to 20th Community-Led Project Advancing Maternal Health Equity During Black Maternal Health Week
April 15, 2021
Tags Community Development NYSE:MRK Philanthropy & Cause Initiatives
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Merck to Discontinue Development of MK-7110 for COVID-19
April 15, 2021
From Business Wire News Releases
Merck and Ridgeback Biotherapeutics Provide Update on Progress of Clinical Development Program for Molnupiravir, an Investigational Oral Therapeutic for the Treatment of Mild-to-Moderate COVID-19
April 15, 2021
From Business Wire News Releases
Noteworthy ETF Inflows: VT, ADBE, CSCO, MRK
April 19, 2021
Tags ETFs
From ETF Channel
BofA Says GlaxoSmithKline's Decision To Halt Feladilimab Studies Is Disappointing
April 15, 2021
Tags Graham Parry Analyst Ratings Reiteration
From Benzinga
Market Briefing For Monday, April 19
April 18, 2021
Tags Stocks / Equities Pharma/Biotech Market News
From Blogs - TalkMarkets
Merck Expands Safer Childbirth Cities Initiative to 20th Community-Led Project Advancing Maternal Health Equity During Black Maternal Health Week
April 14, 2021
From Business Wire News Releases
Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine
April 15, 2021
Tags CH:NOVN MRK NVS
From MarketWatch
Merck & Co: Debt Overview
April 15, 2021
Tags BZI/Debt News Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media